Last reviewed · How we verify
Skin test panel and desensitization kit — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Skin test panel and desensitization kit (Skin test panel and desensitization kit) — EVE Medical Systems Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Skin test panel and desensitization kit TARGET | Skin test panel and desensitization kit | EVE Medical Systems Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Skin test panel and desensitization kit CI watch — RSS
- Skin test panel and desensitization kit CI watch — Atom
- Skin test panel and desensitization kit CI watch — JSON
- Skin test panel and desensitization kit alone — RSS
Cite this brief
Drug Landscape (2026). Skin test panel and desensitization kit — Competitive Intelligence Brief. https://druglandscape.com/ci/skin-test-panel-and-desensitization-kit. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing